Clinically insignificant prostate cancer suitable for active surveillance according to Prostate Cancer Research International: Active surveillance criteria: Utility of PI-RADS v2.
Jae Hyun YimChan Kyo KimJae-Hun KimPublished in: Journal of magnetic resonance imaging : JMRI (2017)
4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:1072-1079.